• Thalocan
  • Lesion Area
  • Mapping Assistant
  • Patent Pending
  • Expert Guidance
  • Guidance
  • on the clinical
  • endpoint
  • landspace
  • Thalocan Assessment
  • Validation Online System
  • Extensive disease
  • state photo library
  • and custom
  • 3D animations
  • The first eCOA
  • specifically
  • built for
  • dermatology
  • Training authored by
  • globally recognized
  • KOLs

Lesion Area Mapping Assistant

Expert guidance on the clinical endpoint landspace

Thalocan Validation Online System

Extensive disease state photo library and custom 3D animations

The first eCOA specifically built for dermatology

Training authored by globally recognized KOLs

Thalocan is revolutionizing the clinical assessment of dermatological diseases with cutting-edge tools designed to enhance every stage of the clinical trial process. Our solutions address common issues that delay trials, ensuring faster and more accurate endpoint data capture.
KEY BENEFITS INCLUDE:

Trialists can collect precise
endpoint data more efficiently.
Patient experience during
study visits is significantly improved.
Medical monitors gain unprecedented
real-time access to study data.

Our mission is the continuous improvement of clinical endpoint data and the simplification of navigating the study endpoint scale landscape,
empowering researchers to optimize trial outcomes and streamline operations.